Psychophysiological evidence of altered neural synchronization in cannabis use: relationship to schizotypy.
Patrick D. Skosnik, Giri P Krishnan, Erin E Aydt, Heidi A Kuhlenshmidt, Brian F O'Donnell
American Journal of Psychiatry October 2006 DOI: 10.1176/ajp.2006.163.10.1798 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 33 |
| Population | Current cannabis users and drug-naive comparison subjects |
| Measures | EEG spectral power, signal-to-noise ratio, Schizotypal Personality Questionnaire |
| Topics | Cannabis |
| Key findings | Cannabis users showed decreased EEG power and signal-to-noise ratio at 20 Hz stimulation, and increased schizotypal personality scores that correlated positively with years of cannabis use. Within the cannabis group, 20-Hz power negatively correlated with schizotypy scores, suggesting neural synchronization deficits and a potential link to schizophrenia spectrum disorders. |
Abstract
Cannabis use may produce neurophysiological disturbances similar to those observed in schizophrenia, particularly in relation to altered neural synchronization. Therefore, the current experiment examined the effect of cannabis use on EEG neural synchronization using the auditory steady-state evoked potential. Auditory steady-state evoked potentials were assessed using varying rates of stimulation (auditory click-trains of 20, 30, 40 Hz) in current cannabis users (N=17) and drug-naive comparison subjects (N=16). EEG spectral power and signal-to-noise ratio at each stimulation frequency were compared between groups. Cannabis users showed decreased EEG power and signal-to-noise ratio at the stimulation frequency of 20 Hz. In addition, current cannabis users demonstrated increased schizotypal personality characteristics as assessed with the Schizotypal Personality Questionnaire, which positively correlated with total years of cannabis use. Finally, within the cannabis group, 20-Hz power values were negatively correlated with Schizotypal Personality Questionnaire scores. These data provide evidence for neural synchronization and early-stage sensory processing deficits in cannabis use. This finding, along with the observed increased rates of schizotypy in cannabis users, adds support for a cannabinoid link to schizophrenia spectrum disorders.
Comparable studies
Other observational and cohort studies on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| High-potency cannabis and the risk of psychosis People with first episode of psychosis and healthy controls from the local population | 2009 | Case-control study | n = 454 |
| Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Rural aboriginal population | 2013 | Observational study | |
| Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people | 2000 | Observational | |
| Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study Individuals from the general population in Germany aged 14-24 at baseline | 2011 | Observational cohort | n = 1,923 |
| Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases Patients treated for cannabis-induced psychotic symptoms in Denmark between 1994 and... | 2005 | Observational cohort | n = 535 |
Citations in the library
Cited by 14
- Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research Frontiers in Pharmacology June 21, 2017
- The Relationship Between Cannabinoids and Neural Oscillations: How Cannabis Disrupts Sensation, Perception, and Cognition Clinical EEG and Neuroscience November 25, 2022
- Is there a common vulnerability in cannabis phenomenology and schizotypy? The role of the N170 ERP. Schizophrenia Research July 2018
- Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans. Neuropharmacology June 2018
- Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans. Neuropsychopharmacology August 2015
and 9 more in the library
Cites 5
- The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology August 2004
- Marijuana alters the human cerebellar clock. Neuroreport June 11, 2003
- Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study Psychological Medicine 2003
- Elevated endogenous cannabinoids in schizophrenia. Neuroreport June 3, 1999
- Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences March 1990